7th Circ. Reverses Boehringer Depo Order In Pradaxa MDL

By Jeff Sistrunk (January 24, 2014, 10:20 PM EST) -- The Seventh Circuit on Friday ruled that a lower court in Illinois overstepped its authority in requiring employees of Germany-based Boehringer Ingelheim International GmbH to be deposed in the U.S. in personal injury multidistrict litigation over the blood thinner Pradaxa. 

In a 2-1 ruling, the appellate court said U.S. District Judge David R. Herndon did not have the authority to require BII and U.S. unit Boehringer Ingelheim Pharmaceuticals Inc. to make foreign employees available for depositions in New York City or elsewhere in the U.S. The judge imposed that requirement, as well as a nearly $1 million fine, in a Dec....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!